John B. Hoopingarner

Emergent Technologies, Inc. (Emergent Technologies) is a venture capital firm founded in 1989 by Thomas A. Harlan. The firm is headquartered in Austin. Texas.

Mimetic Solutions LLC develops and distributes drugs and chemicals. Its product brands include TheraSmart and BeautySmart. The company was founded by Nicholas A. Peppas and Zach J. Hilt in 2006 and is headquartered in Austin, TX.

Heparinex LLC operates as a biopharmaceutical company. It focuses on the novel recombinant synthesis of compounds for the anticoagulation market and associated markets and the dermal filler market. The firm maintains partnerships in the areas of medical device coatings; novel autoimmune and infectious disease and cancer drug discovery and dermal fillers. The company was founded in 2002 and is headquartered in Oklahoma City, OK.

Receptor Logic, Inc. provides a novel solution for the treatment of infectious diseases and cancers. The company was founded by Jon Weidanz in 2003 and is headquartered in Austin, TX.

Hyalose LLC operates as a biotechnology company. It focuses on the commercialization of unique recombinant technologies for producing Hyaluronic Acid (HC). It offers Select-HA, Select-HA HiLadder, Select-HA MegaLadder, and Select-HA LoLadder. The company was founded by Paul L. DeAngelis and Paul H. Weigel in 2000 and is headquartered in Oklahoma City, OK.

Choncept LLC produces biotechnology products. It develops chondroitin from fermentation of recombinant bacteria to replace the current chondroitin source of beef and other animal by-products. The company was founded by Paul L. DeAngelis in 2002 and is headquartered in Oklahoma City, OK.

AeonClad Coatings LLC develops plasma coating for medical devices and other specialty products. It offers fluoropolymers, pigments and reinforcing-protective agents for immediate incorporation into paint, polymers and other materials. The company was founded by Richard B. Timmons in 2007 and is headquartered in Austin, TX.

Pure Protein LLC specializes in immunology tools for diagnostics, drug and vaccine development, and high-yield protein production. It operates as a biopharmaceutical company, produces soluble human leukocyte antigen (sHLA) proteins and custom products in various human and animal cell lines. The firm provides sHLA class I and II proteins for use in transplantation, drug target discovery, and bio-therapeutic development, as well as diagnostic and therapeutic reagents for use in immunology research and development. The company was founded by William Hildebrand in 1999 and is headquartered in Austin, TX.